Pharvaris NV
Pharvaris NV (PHVS) Covered Calls
As of September 25, 2026, PHVS has 18 covered call opportunities in the coming three months. Return ranges from 9.5 to 72.1% until expiration. Annualized return ranges from 39.6 to 710.0%. The nearest expiration is October 16, 2026. Maximum potential profit is $2,308.
Read more
Running PHVS covered calls helps you generate consistent income from Pharvaris NV's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Pharvaris NV involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PHVS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PHVS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PHVS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Pharvaris NV covered call is worth writing.
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States.
The company was incorporated in 2015 and is based in Leiden, the Netherlands.
Income-focused investors, long-term PHVS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PHVS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Pharvaris NV covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)2,237
- 52 weeks high-25.97%
- 52 weeks low55.06%
- Analyst recommendationStrong Buy
1.13 - Target price$57.90
80.82% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-3.05
- EPS growth next 5 years33.00%
As of September 25, 2026
| 2026-10-16 | 21 | 45.00 | 40.54 | 0.10 | 0.25 | 1308.00 | 40.85 | 710.00 | -0.31 | +0.06 | 734 | 0.15 |
| 2026-11-20 | 56 | 45.00 | 40.54 | 0.35 | 4.90 | 1333.00 | 41.63 | 271.34 | -1.09 | +0.33 | 2 | 4.55 |
| 2026-12-18 | 84 | 50.00 | 56.15 | 0.70 | 4.90 | 1868.00 | 58.34 | 253.49 | -2.19 | +0.31 | 5 | 4.20 |
| 2027-01-15 | 112 | 50.00 | 56.15 | 0.05 | 4.90 | 1803.00 | 56.31 | 183.51 | -0.16 | +0.29 | 10 | 4.85 |
| 2026-12-18 | 84 | 45.00 | 40.54 | 0.05 | 4.90 | 1303.00 | 40.69 | 176.82 | -0.16 | +0.32 | 3 | 4.85 |
| 2026-11-20 | 56 | 40.00 | 24.92 | 0.10 | 4.90 | 808.00 | 25.23 | 164.47 | -0.31 | +0.36 | 41 | 4.80 |
| 2026-10-16 | 21 | 35.00 | 9.31 | 0.05 | 3.00 | 303.00 | 9.46 | 164.47 | -0.16 | +0.37 | 197 | 2.95 |
| 2027-03-19 | 175 | 55.00 | 71.77 | 0.10 | 4.90 | 2308.00 | 72.08 | 150.34 | -0.31 | +0.28 | 1 | 4.80 |
| 2027-01-15 | 112 | 45.00 | 40.54 | 0.05 | 4.90 | 1303.00 | 40.69 | 132.62 | -0.16 | +0.32 | 12 | 4.85 |
| 2027-03-19 | 175 | 50.00 | 56.15 | 0.05 | 4.90 | 1803.00 | 56.31 | 117.44 | -0.16 | +0.30 | 2 | 4.85 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best PHVS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→